Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Northwest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (the "REIT" or "Northwest"), a leading owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia, announced today that the Trustees of the REIT have declared a distribution of $0.03 per unit for the month of July 2025, representing $0.36 per unit on an annualized basis. The distribution will be payable on August 15, 2025, to unith ...

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program (EAP) designed to empower a more engaged, healthier workforce. The new program, purpose-built for the company’s employer and health plan clients in the U.S., leverages Teladoc Health’s unmatched scale, clinical product portfolio and consumer engagement expertise to help organizations create a powerful “on-ramp” for long-te ...

科创板深化改革 - 科创板深化改革细则增强资本市场对科技创新和新质生产力发展的制度包容性，科创成长层的设置彰显政策支持导向 [1] - 未盈利企业上市通道开启，预期后续会有更多未盈利科创企业申报IPO [1] - 改革对新股发行带来结构性影响，结合6月受理潮显效，预期25H2新股发行节奏小幅提速，下半年或迎未盈利科创企业上市 [1] - 中性情形下，25H2预测2亿元优配/非优配对象收益率为2.79%/2.54% [1] - 预先审阅机制正式启动后，IPO审核效率将进一步提升，审核周期或将缩短，吸引更多科创企业积极申报科创板IPO [1] 科创创业ETF - 科创创业ETF跟踪的是科创创业50指数，单日涨跌幅可达20% [1] - 科创创业50指数由中证指数有限公司编制，从科创板与创业板市场中精选市值大、流动性好的50只科技及创新型企业股票作为指数样本 [1] - 指数覆盖信息技术、医疗保健等多个高成长性行业，旨在反映中国科技创新领域上市公司证券的整体表现 [1]

打开热门网络平台，不时有"妇科医生"给男士T恤带货，"骨科医生"推销美容产品，"神经康复科"医生 侃侃而谈食用益生菌的好处；还有人穿上白大褂、伪造专家资质，堂而皇之地向用户推荐药品。这 些"假科普、真带货"的视频，在老年群体中十分受欢迎。 当前，随着公众健康意识增强，医疗科普领域热度不断提升。新华每日电讯记者调查发现，一些网络平 台上本应传递专业知识、守护大众健康的医疗科普，近来却在流量裹挟下"变了味"：从"耸人听闻"误导 受众，再到利用"擦边话题"博眼球，部分医疗从业者在平台上利用自身专业光环，以科普之名行"牟利 之实"。种种行为不仅消解了行业公信力，更置患者健康于风险之中。 明面科普，暗地里全是"生意" 一些平台对医疗从业者的身份审核漏洞，也助长了"造假引流"的气焰。很多账号并无认证信息，仅 凭"白大褂""手术服"等元素，以及与医疗相关的用户名便擦边带货。 "有的'网红医生'把医疗科普当作牟利工具，滥用专业权威为自己背书，假借科普名义违规导医导诊， 线上问诊，线下引流，直播带货……"7月4日，国家卫健委召开新闻发布会，新闻发言人胡强强指出当 前互联网健康科普存在的问题，再次将长期存在却未得到根治的医疗科普 ...

Key Takeaways UNH's commercial insurance segment covered over 30M members as of March 2025. Favorable pricing and a healthier risk pool make commercial plans more stable than Medicare Advantage. UNH is leaning on commercial strength as it tightens controls across its Medicare operations.UnitedHealth Group Inc. (UNH) is currently navigating a challenging healthcare landscape, with its Medicare Advantage business reportedly facing regulatory scrutiny and rising care costs. However, amid all the hurdles, its ...

Key Takeaways Ventas has outperformed the industry with an 11.6% stock gain in the past six months. VTR expects senior housing and outpatient NOI growth, fueled by aging demographics. Liquidity of $3.6B and accretive investments in research portfolio strengthen Ventas' growth outlook.Shares of Ventas (VTR) have gained 11.6% in the past six months compared with the industry’s 6% growth.This Chicago-based healthcare real estate investment trust (”REIT”) is well-poised to benefit from its diverse portfolio o ...

Key Takeaways ELV is set to report Q2 earnings of $9.20 per share on $48.13B in revenues, which is up 11.4% YoY. Product and premium revenues, along with CarelonRx growth, are expected to support Q2 top-line gains. Higher benefit expenses and interest expenses may weigh on margins, with costs up nearly 11% YoY.Elevance Health, Inc. (ELV) is set to report its second-quarter 2025 results on July 17, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is curr ...

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchan ...

New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient CensusDETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Developed in direct response to customer demand, NurseMagic™ Enterprise integrates advanc ...

报告行业投资评级 - 报告对各公司给出了不同评级，如Asymchem（6821.HK、002821.SZ）为买入（B）评级，Tigermed（300347.SZ）、WuXi XDC（2268.HK）等为中性（N）评级，MicroTech（2235.HK）为卖出（S）评级 [11] 报告的核心观点 - 进入2025年第二季度财报季，投资者对CRO/CDMO、Medtech和Services领域的潜在交易机会兴趣增加，生物技术/制药行业表现强劲后，CDMO板块的二季度财报发布可能催化积极情绪和交易机会 [1] - 为契合近期行业趋势和管理层评论，更新模型并调整2025 - 2027年的每股收益（EPS）估计，平均调整幅度为1.3%/1.4%/0.9%，目标价格（TP）平均变化4% [1] 根据相关目录分别进行总结 CRO/CDMO - 预计盈利相对有韧性，特别是在后期开发和制造项目以及新模态方面有更多业务的公司，如Asymchem、WuXi Apptec、WuXi XDC [2] - 投资者关注新订单增长、客户行为变化迹象、定价和利润率恢复以及新增长机会等方面 [2] - 部分公司的目标价格和每股收益估计有调整，如Asymchem目标价格上调13%，Tigermed目标价格上调11%等；部分公司的销售和盈利增长预期不同，如WuXi XDC 2025 - 2026年销售增长分别为40%、33% [11][13] - 各公司的积压订单和新订单情况不同，如WuXi Apptec 2025年第一季度积压订单同比增长47%，新订单同比增长25% [17] - 各公司给出了2025财年的业绩指引，如WuXi Apptec预计2025年持续运营业务收入增长10 - 15%，WuXi XDC预计2025年销售增长超过35% [19] Medtech - 预计2025年下半年复苏更明显，受基数效应和医院活动正常化支持 [3] - 关注重点包括VBP推出节奏、手术量趋势、新产品贡献和全球化进展等 [3] - 部分公司的目标价格和每股收益估计有调整，如Kangji Medical目标价格上调10%，Angelalign的每股收益估计有调整 [11][13] - 各公司给出了2025财年的业绩指引，如AK Medical预计2025年净利润与市场共识一致，Angelalign预计2025年海外病例量同比增长50% [19] Services - 报销控制和DRG/DIP压力可能在定价和交易量上持续存在，关注定价竞争和消费相关类别消费复苏信号以及并购意愿 [4] - 部分公司的目标价格和每股收益估计有调整，如Hygeia目标价格下调13%，Gushengtang目标价格基本不变 [11][13] - 各公司给出了2025财年的业绩指引，如Gushengtang预计2025年营收增长超过25%，并新增15 - 20家新店 [19] 资金情况 - 6月美国和中国的公共资金活跃，而私人资金仍不活跃 [20][22]